Prophase Labs Inc (PRPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20 | 31 | 90 | 405 | 169 |
| Marketable Securities | N/A | N/A | N/A | N/A | 2 |
| Receivables | 1,543 | 1,543 | 1,536 | 3,284 | 20,086 |
| Inventories | 70 | 70 | 70 | 266 | 830 |
| TOTAL | $2,802 | $3,113 | $3,150 | $7,773 | $24,571 |
| Non-Current Assets | |||||
| PPE Net | 1,392 | 1,709 | 2,032 | 2,349 | 3,581 |
| Investments And Advances | 43,219 | 43,266 | 43,491 | 43,657 | 0 |
| Intangibles | 9,844 | 10,490 | 11,135 | 11,781 | 13,690 |
| Other Non-Current Assets | 152 | 152 | 63 | 142 | 199 |
| TOTAL | $54,607 | $55,617 | $56,721 | $57,929 | $17,470 |
| Total Assets | $57,409 | $58,730 | $59,871 | $65,702 | $42,041 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,586 | 5,409 | 5,155 | 954 | 2,425 |
| Accounts payable and accrued liabilities | 43,373 | 41,741 | 40,561 | 45,033 | 15,421 |
| Accrued Expenses | 50 | 50 | 50 | 151 | 226 |
| Other current liabilities | 3,400 | 3,221 | 2,709 | 4,904 | 2,035 |
| TOTAL | $58,087 | $56,108 | $53,081 | $55,287 | $25,626 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 436 |
| Deferred Revenues | 1,438 | 1,840 | 1,501 | 1,374 | 1,418 |
| Other Non-Current Liabilities | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 |
| TOTAL | $2,433 | $3,236 | $3,282 | $3,554 | $4,979 |
| Total Liabilities | $60,520 | $59,344 | $56,363 | $58,841 | $30,605 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,593 | 14,016 | 14,016 | 4,618 | 4,154 |
| Common Shares | 7 | 7 | 4 | 29 | 29 |
| Retained earnings | -81,362 | -78,490 | -73,136 | -65,738 | -58,899 |
| Other shareholders' equity | 159 | 159 | 159 | 159 | 161 |
| TOTAL | $-3,111 | $-614 | $3,508 | $6,861 | $11,436 |
| Total Liabilities And Equity | $57,409 | $58,730 | $59,871 | $65,702 | $42,041 |